Xavier Poiré
About
Xavier Poiré is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, Xavier Poiré has authored 69 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hematology, 20 papers in Oncology and 20 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Xavier Poiré's work include Hematopoietic Stem Cell Transplantation (29 papers), Acute Myeloid Leukemia Research (26 papers) and Acute Lymphoblastic Leukemia research (20 papers). Xavier Poiré is often cited by papers focused on Hematopoietic Stem Cell Transplantation (29 papers), Acute Myeloid Leukemia Research (26 papers) and Acute Lymphoblastic Leukemia research (20 papers). Xavier Poiré collaborates with scholars based in Belgium, France and Germany. Xavier Poiré's co-authors include Johan Maertens, Arnon Nagler, Mohamad Mohty, Myriam Labopin, Koen van Besien, Oliver Witzke, Tessa Kerre, Catherine Cordonnier, Ibrahim Yakoub‐Agha and Péter Jaksch and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Xavier Poiré
64 papers receiving 956 citations
Peers
Xavier Poiré
Arjun Law Canada
Inmaculada Heras Spain
Amer Beitinjaneh United States
Roni Tamari United States
Pascual Balsalobre Spain
Erden Atilla Türkiye
Eugenia Giraldi Italy
Elizabeth Rich United States
Marianna Criscuolo Italy
Anu Korula India
Citations per year, relative to Xavier Poiré Xavier Poiré (= 1×)
peers
Arjun Law
Countries citing papers authored by Xavier Poiré
Since
Specialization
Citations
This map shows the geographic impact of Xavier Poiré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Poiré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Poiré more than expected).
Fields of papers citing papers by Xavier Poiré
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Xavier Poiré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Poiré. The network helps show where Xavier Poiré may publish in the future.
Co-authorship network of co-authors of Xavier Poiré
This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Poiré. A scholar is included among the top collaborators of Xavier Poiré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Poiré. Xavier Poiré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Poiré, Xavier, Myriam Labopin, Emmanuelle Polge, et al.. (2025). Older matched sibling donor vs young haploidentical donor for older patients with acute myeloid leukemia. Blood Advances. 9(20). 5192–5200.
2.
Malard, Florent, Ernst Holler, Zinaida Perić, et al.. (2025). Microbiotherapy and fecal microbiota transplantation in hematology-oncology: a European clinical perspective to navigate the evolving regulatory framework and the emergence of a new therapeutic class. Bone Marrow Transplantation. 61(2). 125–127.
3.
Jadot, G, Xavier Poiré, Renaud Lhommel, & Guillaume Dachy. (2024). 18FDG PET/CT imaging of adenovirus‐associated acute interstitial nephritis after allogeneic bone marrow transplantation. SHILAP Revista de lepidopterología. 12(8). e9110–e9110.
4.
Chevret, Sylvie, Xavier Poiré, Magalie Joris, et al.. (2024). Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. Bone Marrow Transplantation. 59(7). 965–973.
5.
Filosto, Simone, Saran Vardhanabhuti, Miguel Canales, et al.. (2023). Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7). Blood Cancer Discovery. 5(1). 21–33.
6.
Poiré, Xavier, Myriam Labopin, Emmanuelle Polge, et al.. (2023). Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with hyperdiploid complex karyotype. Bone Marrow Transplantation. 59(2). 264–269.
7.
Wérion, Alexis, Claire Beguin, J. A. Bernards, et al.. (2023). Epidemiology, Outcomes, and Complement Gene Variants in Secondary Thrombotic Microangiopathies. Clinical Journal of the American Society of Nephrology. 18(7). 881–891.
8.
Epstein‐Peterson, Zachary D., Andriy Derkach, Susan M. Geyer, et al.. (2022). Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia. Blood Advances. 6(11). 3433–3439.
9.
Poiré, Xavier, Myriam Labopin, Emmanuelle Polge, et al.. (2018). Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission. American Journal of Hematology. 94(2). 231–239.
10.
Vos, John De, Étienne Baudoux, Jacques‐Olivier Bay, et al.. (2018). Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 106(1). S35–S39.
11.
Robinson, Stephen, Ariane Boumendil, Karl S. Peggs, et al.. (2018). Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party. Bone Marrow Transplantation. 53(5). 617–624.
12.
Giebel, Sebastian, Myriam Labopin, Michael Potter, et al.. (2018). Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT. European Journal of Cancer. 96. 73–81.
13.
Poiré, Xavier, Myriam Labopin, Emmanuelle Polge, et al.. (2017). Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica. 103(2). 256–265.
14.
Poiré, Xavier, Myriam Labopin, Johan Maertens, et al.. (2016). Allogeneic stem cell transplantation in adult patients with acute myeloid leukemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European society of Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 51.
15.
Robinson, Stephen, Ariane Boumendil, Hervé Finel, et al.. (2015). Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party. Bone Marrow Transplantation. 51(3). 365–371.
16.
Labopin, Myriam, Emmanuelle Polge, G. Socié, et al.. (2013). A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality. Bone Marrow Transplantation. 49(3). 376–381.
17.
Poiré, Xavier, Barry Kurt Moser, Robert E. Gallagher, et al.. (2013). Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype. Leukemia & lymphoma. 55(7). 1523–1532.
18.
Jain, Nitin, Emily Curran, Neil M. Iyengar, et al.. (2012). Phase II study of the oral MEK inhibitor selumetinib (AZD6244) in advanced acute myeloid leukemia (AML).. Journal of Clinical Oncology. 30(15_suppl). 6582–6582.
19.
Poiré, Xavier, Justin Kline, David L. Grinblatt, et al.. (2010). Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas. Leukemia & lymphoma. 51(7). 1241–1250.
20.
Théate, Ivan, et al.. (2009). Diffuse xanthomatosis as a presenting feature of multiple myeloma. European Journal Of Haematology. 84(5). 460–461.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Arjun Law Breakdown of academic impact, for papers by Inmaculada Heras Breakdown of academic impact, for papers by Amer Beitinjaneh Breakdown of academic impact, for papers by Roni Tamari Breakdown of academic impact, for papers by Pascual Balsalobre Breakdown of academic impact, for papers by Erden Atilla Breakdown of academic impact, for papers by Eugenia Giraldi Breakdown of academic impact, for papers by Elizabeth Rich Breakdown of academic impact, for papers by Marianna Criscuolo Breakdown of academic impact, for papers by Anu Korula